Welcome to CPUpdates (CPU)

CPU’s vision is to be the UK’s best training experience. Being the best means providing outstanding quality training, service and value, so that CPU can be the first choice for Healthcare Professionals. Our Mission is to achieve excellence in the training we provide.

Above all we want healthcare professionals to enjoy our courses.

Please note the dates and venues for June courses have been changed due to refurbishment work at Holiday Inn South Wimbledon.

Latest Updates

Updates For May 2012

Clinical Pharmacy Updates Courses on 7th,16th & 18th June 2012

Please note the change of venues on 16th June. This course is now held at St Heliers Hospital, Carshalton, Surrey SM5 1AA, at the Post Graduate Medical Centre.

For further information please contact one of our friendly staff by filling out the ‘Contact Us’ form on the website.

Alternatively you may email us at: cpupdates@hotmail.co.uk

or speak to us directly on 07947764158.

Terms and conditions apply

If you haven’t booked your place yet please do so as soon as possible.

Limited places left. Book now to avoid disappointment!

N.B: Places will be allocated on a first come first serve basis!

Book a full day course on 7th or 16th June and get the course on 18th June for half price. For group bookings enquiries please contact us on the number above.

May Updates

17 May 2012

Class 3 Medicines Recall – Action within 5 days – Pharmacy level recall -MHRA- http://www.mhra.gov.uk/Publications/Safetywarnings/DrugAlerts/CON152696

Fulsovin (Griseofulvin) oral suspension 125mg/5ml
(manufactured by Kappin)

PL 20249/0009

All remaining stock of the above product is being recalled because stability tests have shown that the product does not comply with the required specifications for the duration of the shelf life.

All remaining stock should be quarantined and returned to the original supplier for credit.

No further batches of Fulsovin (Griseofulvin) oral suspension 125mg/5ml will be released until the issue has been resolved.

There is no direct alternative for some paediatric indications and if a prescription is received there is an unlicensed product available. Pharmacists should, however, seek assurances that the product they supply incorporates a Griseofulvin drug substance that is in full compliance with the requirements of the Ph.Eur/BP monograph including the particle size distribution described in the monograph.

For medical information enquiries, please contact Kappin Limited, telephone 0208 9618511, emailorbispv@orbiscpl.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Primary Care Trusts are asked to forward this to relevant clinics and to General Practitioners and Community Pharmacists for information.

3rd May 2012 - MHRA Class 4 Drug Alert - Priadel Liquid containing Lithium Citrate 520mg/5ml equivalent to lithium carbonate 204mg/5ml (Sanofi)

Sanofi has informed the MHRA that several reports have been received by them with regards to this preparation. It appears Cloudy instead of clear; which seems to be due to Xanthan gum used as one of the excipients. Read more ..........http://www.mhra.gov.uk/Publications/Safetywarnings/Drugalerts/CON049188

MHRA have launched a learning module on opiods - learning about reducing medicines risk - Drug Saftey Update Volume 5 issue 9 April 2012

NICE

NICE have published a draft clinical guidelines for Crohn's disease in adults and children, consultation period for this guidline runs from 3rd May to 14th June 2012. to access these visit NICE at: http://guidance.nice.org.uk/CG/Wave22/2

Updates For May 2012

May 2012 News Bulletin

Changes to controlled drugs legislation for nurse and pharmacist independent prescribers come into force as of 23rd April 2012.

This allows Pharmacists and Nurse non-medical prescribers to prescribe any schedule 2-5 controlled drug within their clinical competence, and has removed the previous limitations. Pharmacist independent prescribers can prescribe any schedule 2-5 controlled drug within their clinical competence under this legislation. Nurse and pharmacist independent prescribers, and supplementary prescribers within the terms of a clinical management plan, is also allowed to mix schedule 2-5 controlled drugs for administration to a patient and provide written directions for others to do so under thiese regulations. For further information visit: The Misuse of Drugs (Amendment No.2) (England, Wales and Scotland) Regulations 2012 http://www.legislation.gov.uk/uksi/2012/973/contents/made and guidance at RPS website http://www.rpharms.com/support-alerts/support-alert-article.asp?id=513

March updates

The cost of NHS prescriptions in England will rise 25p to £7.65 from 1 April, the government has announced

NICE UPDATES

NICE TA 248 Diabetes (type2) - Prolonged - release suspension for injection in combination with oral anti-diabetic therapy for the treatment of type 2 diabetes ... read more here http://guidance.nice.org.uk/TA248

NICE issues clinical guideline CG137

on the diagnosis and management of Epilepsy

in adults and children in primary and secondary care

NICE issues guideline on preventing type 2 diabetes:

risk identification and

intervention for individuals at high risk;

draft guidance consultation.

expected issue May 2012.